financetom
Business
financetom
/
Business
/
Chevron CEO says no discussions with President-elect Trump on Venezuela
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chevron CEO says no discussions with President-elect Trump on Venezuela
Dec 6, 2024 12:10 PM

HOUSTON (Reuters) - Chevron ( CVX ), the only U.S. oil producer now working in Venezuela's oilfields, has not held any discussions with President-elect Donald Trump's team over the company's operations in the country, CEO Michael Wirth said on Friday.

In 2019, the first Trump administration imposed sweeping sanctions on state-oil firm Petroleos de Venezuela aimed to curb its oil exports and force a change in governments. But Chevron ( CVX ) has been allowed since 2022 to export oil to recoup unpaid dividends from joint venture partners.

Chevron ( CVX ) aims to support U.S. policy on Venezuela while providing a better future to Venezuelans, Wirth said in remarks to think tank Atlantic Council.

"We are trying to hang in there, work with our government," Wirth said.

"As other companies have left Venezuela, they've been replaced, by and large, with companies from two countries, Russia and China and if we were to leave, that, no doubt, is where the operations that we're involved with would likely end up as well," he added.

The easing of restrictions on Chevron ( CVX ) and other oil firms came under the administration of U.S. President Joe Biden and it is unclear what the incoming Trump administration's policy will be.

Oil shipments last month to the U.S. from Venezuela by Chevron ( CVX ) under a 2022 authorization from the Biden administration were 238,000 barrels per day.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Veru's Enobosarm Meets Primary Endpoint of Preserving Lean Body Mass in Phase 2b Study
Veru's Enobosarm Meets Primary Endpoint of Preserving Lean Body Mass in Phase 2b Study
Jan 27, 2025
08:15 AM EST, 01/27/2025 (MT Newswires) -- Veru ( VERU ) said Monday that a phase 2b clinical trial of enobosarm for overweight and obese patients receiving Wegovy met its primary endpoint of preserving lean body mass in 16 weeks. In the study, overweight and obese patients, over 60 years old, receiving Wegovy showed a 71% reduction in lean body...
CIBC Launching Its First European Canadian Depositary Receipts
CIBC Launching Its First European Canadian Depositary Receipts
Jan 27, 2025
08:13 AM EST, 01/27/2025 (MT Newswires) -- CIBC (CM.TO, CM) on Monday announced the expansion of its Canadian Depositary Receipts platform with the addition of five new 'European CDRs', to be listed on Cboe Canada and available for trading on January 31, 2025, subject to final approval by the Exchange. A statement noted CIBC's first European CDRs are based on...
QXO goes hostile in bid to buy Beacon Roofing for $11 billion
QXO goes hostile in bid to buy Beacon Roofing for $11 billion
Jan 27, 2025
Jan 27 (Reuters) - QXO on Monday took its $11 billion takeover offer to Beacon Roofing's shareholders after the building-products distributor rebuffed its overtures. Beacon's shares were trading at $118.56 before the bell, below the offer price of $124.25 per share, while QXO's stock was marginally higher. The development comes after Beacon earlier this month rejected a $11 billion takeover...
Allakos to Discontinue Development of Urticaria Treatment, Cut Staff; Shares Fall
Allakos to Discontinue Development of Urticaria Treatment, Cut Staff; Shares Fall
Jan 27, 2025
08:08 AM EST, 01/27/2025 (MT Newswires) -- Allakos ( ALLK ) said Monday that its phase 1 trial of AK006 in chronic spontaneous urticaria failed to demonstrate therapeutic efficacy and its development will be terminated immediately. The company said it plans to cut its workforce by 75% and retain a small team to explore strategic options and ensure regulatory compliance....
Copyright 2023-2026 - www.financetom.com All Rights Reserved